Psoriatic arthritis A. clinical features

Primer on the Rheumatic Diseases: Thirteenth Edition

Volumn , Issue , 2008, Pages 170-177

  Gladman, Dafna D ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79951697065     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-68566-3_8     Document Type: Chapter

References (75)

1. Wright V, Moll JMH. Psoriatic arthritis. In: Seronegative polyarthritis. Amsterdam: North Holland Publishing; 1976:169-223.
2. Langley RGB, Krueger GG, Griffiths CEM. Psoriasis: epidemiology, clinical features and quality of life. Ann Rheum Dis 2005;64:18-23.
3. Gladman DD, Shuckett R, Russell ML, et al. Psoriatic arthritis (PSA)-an analysis of 220 patients. Q J Med 1987;62:127-141.
4. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H; CASPAR Study Group. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006; 54:2665-2673.
5. Gladman DD. Epidemiology. Psoriatic arthritis. In: Gordon GB, Ruderman E, eds. Psoriasis and psoriatic arthritis: an integrated approach. Heidelberg: Springer-Verlag; 2005:57-65.
6. Madland TM, Apalset EM, Johannessen AE, Rossebo B, Brun JG. Prevalence, disease manifestations, and treatment of psoriatic arthritis in Western Norway. J Rheumatol 2005;32:1918-1922.
7. Shbeeb M, Uramoto KM, Gibson LE, et al. The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982-1991. J Rheumatol 2000;27:1247-1250.
8. Zachariae H. Prevalence of joint disease in patients with psoriasis: implications for therapy. Am J Clin Dermatol 2003;4:441-447.
9. Gelfand JM, Gladman DD, Mease PJ, et al. Epidemiology of psoriatic arthritis in the United States population. J Am Acad Dermatol 2005;53:573-577.
10. Scarpa R, Oriente P, Pulino A, et al. Psoriatic arthritis in psoriatic patients. Br J Rheumatol 1984;23:246-250.
11. Fournie B, Crognier L, Arnaud C, et al. Proposed classi-fication criteria of psoriatic arthritis. A preliminary study in 260 patients. Rev Rheum Engl Ed 1999;66:446-456.
12. Taylor WJ, Marchesoni A, Arreghini M, et al. A comparison of the performance characteristics of classification criteria for the diagnosis of psoriatic arthritis. Semin Arthritis Rheum 2004;34:575-584.
13. Kammer GM, Soter NA, Gibson DJ, et al. Psoriatic arthritis: clinical, immunologic and HLA study of 100 patients. Semin Arthritis Rheum 1979;9:75-97.
14. Helliwell P, Marchesoni A, Peters M, et al. A reevaluation of the osteoarticular manifestations of psoriasis. Br J Rheumatol 1991;30:339-345.
15. Torre Alonso JC, Perez AR, Castrillo JMA, et al. Psori-atic arthritis (PA): a clinical, immunological and radiological study of 180 patients. Br J Rheumatol 1991;30: 245-250.
16. Veale D, Rogers S, Fitzgerald O. Classification of clinical subsets in psoriatic arthritis. Br J Rheumatol 1994;33: 133-138.
17. Jones SM, Armas JB, Cohen MG, et al. Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin disease. Br J Rheumatol 1994;33:834-839.
18. Salvarani C, Macchioni PL, Zizzi F. Clinical subgroups and HLA antigens in Italian patients with psoriatic arthritis. Clin Exp Rheumatol 1989;7:391-396.
19. Scarpa R, Biondi OC, Oriente P. The classification of psoriatic arthritis: what will happen in the future? J Am Acad Dermatol 1997;36:78-83.
20. Marsal S, Armadans-Gil L, Martinez M, Gallardo D, Ribera A, Lience E. Clinical, radiographic and HLA associations as markers for different patterns of psoriatic arthritis. Rheumatology (Oxford) 1999;38:332-337.
21. Kane D, Stafford L, Bresnihan B, FitzGerald O. A clas-sification study of clinical subsets in an inception cohort of early psoriatic peripheral arthritis-"DIP or not DIP revisited". Rheumatology (Oxford) 2003;42:1469-1476.
22. Khan M, Schentag C, Gladman D. Clinical and radiological changes during psoriatic arthritis disease progression: working toward classification criteria. J Rheumatol 2003;30:1022-1026.
23. McHugh NJ, Balachrishnan C, Jones SM. Progression of peripheral joint disease in psoriatic arthritis: a 5-yr prospective study. Rheumatology (Oxford) 2003;42:778-783.
24. Helliwell PS, Hetthen J, Sokoll K, et al. Joint symmetry in early and late rheumatoid and psoriatic arthritis: comparison with a mathematical model. Arthritis Rheum 2000;43:865-871.
25. Buskila D, Langevitz P, Gladman DD, et al. Patients with rheumatoid arthritis are more tender than those with pso-riatic arthritis. J Rheumatol 1992;19:1115-1119.
26. Jajic I. Blue coloured skin in psoriatic arthritis. Clin Exp Rheumatol 2001;19:478.
27. Lambert JB, Wright V. Psoriatic spondylitis: a clinical and radiological description of the spine in psoriatic arthritis. Q J Med 1977;46:411-425.
28. Hanly J, Russell ML, Gladman DD. Psoriatic spondylo-arthropathy: a long term prospective study. Ann Rheum Dis 1988;47:386-393.
29. Salvarani C, Macchioni P, Cromones T, et al. The cervical spine in patients with psoriatic arthritis: a clinical, radiological and immunogenetic study. Ann Rheum Dis 1992;51:73-77.
30. Ballistone MJ, Manaster BJ, Reda DJ, et al. The prev-lance of sacroiliitis in psoriatic arthritis: new perspectives from a large, multicenter cohort. Skeletal Radiol 1999;28: 196-201.
31. Gladman DD, Brubacher B, Buskila D, et al. Differences in the expression of spondyloarthropathy: a comparison between ankylosing spondylitis and psoriatic arthritis. Genetic and gender effects. Clin Invest Med 1993;16: 1-7.
32. Kane D, Gearney T, Bresnihan B, Gibney R, Fitzgerald O. Ultrasonography in the diagnosis and management of psoriatic dactylitis. J Rheumatol 1999;25:1746-1751.
33. Olivieri I, Barozzi L, Favaro L, et al. Dactylitis in patients with seronegative spondyloarthropathy. Arthritis Rheum 1996;39:1524-1528.
34. Brockbank J, Stein M, Schentag CT, et al. Characteristics of dactylitis in psoriatic arthritis (PsA). Ann Rheum Dis 2005;62:188-190.
35. Helliwell PS, Firth J, Ibrahim GH, et al. Development of an assessment tool for dactylitis in patients with psoriatic arthritis. J Rheumatol 2005;32:1745-1750.
36. Cantini F, Salvarani C, Olivieri I, et al. Distal extremity swelling with pitting edema in psoriatic arthritis: a case-control study. Clin Exp Rheumatol 2001;19:291-296.
37. Salvarani C, Cantini F, Olivieri I, et al. Distal extremity swelling with pitting edema in psoriatic arthritis: evidence of 2 pathological mechanisms. J Rheumatol 1999;26: 1831-1834.
38. Salvarani C, Cantini F, Olivieri I, et al. Isolated peripheral enthesitis and/or dactylitis: a subset of psoriatic arthritis. J Rheumatol 1997;24:1106-1110.
39. Cohen MR, Reda DJ, Clegg DO. Baseline relationships between psoriasis and psoriatic arthritis: analysis of 221 patients with active psoriatic arthritis. J Rheumatol 1999; 26:1752-1756.
40. Elkayam O, Ophir J, Yaron M, Caspi D. Psoriatic arthritis: interrelationships between skin and joint manifestations related to onset, course and distribution. Clin Rheumatol 2000;19:301-305.
41. Gladman DD, Anhorn KB, Schachter RK, et al. HLA antigens in psoriatic arthritis. J Rheumatol 1986;13:586-592.
42. Williamson L, Dockerty JL, Dalbeth N, et al. Gastrointestinal disease and psoriatic arthritis. J Rheumatol 2004;31:1469-1470.
43. Scarpa R, Manguso F, D'Arienzo A, et al. Microscopic inflammatory changes in colon of patients with both active psoriasis and psoriatic arthritis without bowel symptoms. J Rheumatol 2000;27:1241-1246.
44. Peters MJ, van der Horst-Bruinsma IE, Dijkmans BA, et al. Cardiovascular risk profile of patients with spondy-larthropathies, particularly ankylosing spondylitis and pso-riatic arthritis. Semin Arthritis Rheum 2004;34:585-592.
45. Bruce IN, Schentag C, Gladman DD. Hyperuricemia in psoriatic arthritis (PsA) does not reflect the extent of skin involvement. J Clin Rheumatol 2000;6:6-9.
46. Gladman DD. Clinical aspects of spondyloarthropathies. Am J Med Sci 1998;316:234-238.
47. Coulton BL, Thomson K, Symmons DPM, et al. Outcome in patients hospitalised for psoriatic arthritis. Clin Rheu-matol 1989;2:261-265.
48. Kane D, Stafford L, Bresniham B, et al. A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience Rheumatology 2003; 42:1460-1468.
49. Gladman DD, Stafford-Brady F, Chang CH, et al. Longitudinal study of clinical and radiological progression in psoriatic arthritis. J Rheumatol 1990;17:809-812.
50. Siannis F, Farewell VT, Cook RJ, et al. Clinical and radiological damage in psoriatic arthritis. Ann Rheum Dis 2006;65:478-481.
51. Gladman DD, Farewell VT, Nadeau C. Clinical indicators of progression in psoriatic arthritis (PSA): multivariate relative risk model. J Rheumatol 1995;22:675-679.
52. Queiro-Silva R, Torre-Alonso JC, Tinture-Eguren T, et al. A polyarticular onset predicts erosive and deforming disease in psoriatic arthritis. Ann Rheum Dis 2003;62: 68-70.
53. Gladman DD, Farewell VT. Progression in psoriatic arthritis: role of time varying clinical indicators. J Rheu-matol 1999;26:2409-2213.
54. Gladman DD, Ng Tung Hing E, Schentag CT, et al. Remission in psoriatic arthritis. J Rheumatol 2001;28: 1045-1048.
55. Blackmore M, Gladman DD, Husted J, et al. Measuring health status in psoriatic arthritis: the Health Assessment Questionnaire and its modification. J Rheumatol 1995; 22:886-893.
56. Husted J, Gladman DD, Long JA, Farewell VT, Cook R. Validating the SF-36 health questionnaire in patients with psoriatic arthritis. J Rheumatol 1997;24:511-517.
57. Sokoll KB, Helliwell PS. Comparison of disability and quality of life in rheumatoid and psoriatic arthritis. J Rheumatol 2001;28:1842-1846.
58. Husted JA, Gladman DD, Farewell VT, et al. Health-related quality of life of patients with psoriatic arthritis: a comparison with patients with rheumatoid arthritis. Arthritis Care Res 2001;45:151-158.
59. Husted JA, Brian T, Farewell VT, et al. Description and prediction of physical functional disability in psoriatic arthritis (psa): a longitudinal analysis using a Markov model approach. Arthritis Rheum 2005;53:404-409.
60. Wong K, Gladman DD, Husted J, et al. Mortality studies in psoriatic arthritis. Results from a single centre. I. Risk and Causes of Death. Arthritis Rheum 1997;40:1868-1872.
61. Gladman DD, Farewell VT, Husted J, et al. Mortality studies in psoriatic arthritis. Results from a single centre. II. Prognostic indicators for mortality. Arthritis Rheum 1998;41:1103-1110.
62. Ali Y, Tom B, Schentag C, et al. Did mortality rate improve in psoriatic arthritis (PsA) patients in the last decade? J Rheumatol 2006;33:386.
63. Chandran V, Schentag CT, Gladman D. A Reappraisal of the effectiveness of methotrexate (MTX) in psoriatic arthritis (PsA): a clinic experience. Arthritis Rheum 2005;52(Suppl 9):S638.
64. Leczinsky CG. The incidence of arthropathy in a ten-year series of psoriasis cases. Acta Derm Venereol 1948;28: 483-487.
65. Vilanova X, Pinol J. Psoriasis arthropathica. Rheumatism 1951;7:197-208.
66. Little H, Harvie JN, Lester RS. Psoriatic arthritis in severe psoriasis. Can Med Assoc J 1975;112:317-319.
67. Leonard DG, O'Duffy JD, Rogers RS. Prospective analysis of psoriatic arthritis in patients hospitalized for psoriasis. Mayo Clin Proc 1978;53:511-518.
68. Green L, Meyers OL, Gordon W, Briggs B. Arthritis in psoriasis. Ann Rheum Dis 1981;40:366-369.
69. Stern RS. The epidemiology of joint complaints in patients with psoriasis. J Rheumatol 1985;12:315-320.
70. Zanelli MD, Wilde JS. Joint complaints in psoriasis patients. Int J Dermatol 1992;31:488-491.
71. Falk ES, Vandbakk Ø. Prevalence of psoriasis in a Norwegian Lapp population. Acta Derm Venereol (Stockh) 1993;182:6-9.
72. Bariic-Druko V, Dobric I, Paic A, et al. Frequency of psoriatic arthritis in general population and among psori-atics in department of dermatology. Acta Derm Venerol (Stockh) 1994;74(Suppl 186):107-108.
73. Salvarani C, Socco GL, Macchioni P, et al. Prevalence of psoriatic arthritis in Italian patients with psoriasis. J Rheu-matol 1995;22:1499-1503.
74. Brockbank JE, Schentag C, Rosen C, et al. Psoriatic arthritis (PsA) is common among patients with psoriasis and family medical clinic attendees. Arthritis Rheum 2001;44(Suppl 9):S94.
75. Alenius GM, Stenberg B, Stenlund H, et al. Inflammatory joint manifestations are prevalent in psoriasis: prevalence study of joint and axial involvement in psoriatic patients, and evaluation of a psoriatic and arthritic questionnaire. J Rheumatol 2002;29:2577-2582.